跳至主要内容
临床试验/ITMCTR1900002685
ITMCTR1900002685尚未招募3 期

A randomized controlled, double-blind study of Chinese medicine combined with EGFR-TKI in the treatment of stage IV EGFR mutation-positive non-small cell lung cancer

Yueyang Hospital of Integrated Traditional Chinese and Western Medicine affiliated to Shanghai University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 80(—)
性别
All

入选标准

  • (1) pathological or cytological diagnosis of stage IV lung cancer with tumor patients;
  • (2) EGFR gene mutations, including exon 19 deletion mutation (19DEL), exon 21 point mutation (21L858R), 18 exon G719X, 20 exon S768I and 21 exon L861Q mutation are also sensitive Sexual mutation, T790M mutation.
  • (3) Age = 18 years old;
  • (4) The estimated survival period is = 3 months;
  • (5) The subject has no major organ dysfunction. Blood routine, liver, kidney, and cardiac function are normal: hemoglobin = 120g / L, absolute neutrophil count (ANC) = 1.5 × 109 / L, platelet = 80 × 109 / L, bilirubin = 1.5ULN, alkaline phosphatase (AP), aspartate aminotransferase (AST) and alanine aminotransferase (ALT) = 2.5 × ULN. INR = 1.5, creatinine = 1.5ULN.

排除标准

  • (1) Have a history of other tumors within 5 years;
  • (2) T790M mutation carrying 20 exons, intended to be treated with EGFR-TKI first-generation drugs;
  • (3) Those with an expected life expectancy of <3 months;
  • (4) symptomatic brain metastases;
  • (5) History of cardiovascular disease: congestive heart failure > level II in NYHA cardiac function. Patients with unstable angina (symptoms of angina at rest) or newly occurring angina (starting in the past 3 months) or myocardial infarction occurred in the past 6 months. Active infection, > Level 2 adverse events (CTC AE. Version 4.0);
  • (6) Pregnant or lactating patients;
  • (7) People with a history of mental illness that is difficult to control.

研究者

发起方
Yueyang Hospital of Integrated Traditional Chinese and Western Medicine affiliated to Shanghai University of Traditional Chinese Medicine

相似试验

已完成
不适用
Randomised, controlled, double-blind trial of Chinese Herbal Medicine as adjuvant treatment in patients with Crohn's diseaseCrohn's diseaseDigestive SystemCrohn's disease [regional enteritis]
ISRCTN69696725Friedrich-Alexander-University of Erlangen-Nuremberg (Germany)60
招募中
不适用
A randomized, double-blind controlled study of the efficacy of infrared-whole body hyperthermia in patients with major depressioF32.1F32.2F33.1F33.2Moderate depressive episodeSevere depressive episode without psychotic symptomsRecurrent depressive disorder, current episode moderateRecurrent depressive disorder, current episode severe without psychotic symptoms
DRKS00015754Klinik für Psychiatrie und PsychotherapieCharité Campus Mitte82
已完成
2 期
Vitamin D supplementation for the treatment of Behcet's diseaseBehcet's disease.Behçet disease
IRCT201212216975N4Vice chancellor for research, Tabriz University of Medical Sciences50
已完成
3 期
Azithromycin in older people with airway diseaseChronic obstructive pulmonary diseaseRespiratory - Chronic obstructive pulmonary diseaseRespiratory - AsthmaAsthma
ACTRN12609000259246Hunter New England Area Health Service40
已完成
不适用
Randomised, double-blind, controlled study of the tranexamic acid prophylaxis efficacy on the development of systemic inflammatory response syndrome and postoperative bleeding in cardiopulmonary bypass surgery patientsSystemic inflammatory response syndrome
ISRCTN05718824niversity Hospital of Canary Islands (Consorcio Sanitario de Tenerife [CST]) (Spain)100